220 related articles for article (PubMed ID: 26413812)
1. JAK2 tyrosine kinase mediates integrin activation induced by CXCL12 in B-cell chronic lymphocytic leukemia.
Montresor A; Toffali L; Mirenda M; Rigo A; Vinante F; Laudanna C
Oncotarget; 2015 Oct; 6(33):34245-57. PubMed ID: 26413812
[TBL] [Abstract][Full Text] [Related]
2. CXCR4- and BCR-triggered integrin activation in B-cell chronic lymphocytic leukemia cells depends on JAK2-activated Bruton's tyrosine kinase.
Montresor A; Toffali L; Rigo A; Ferrarini I; Vinante F; Laudanna C
Oncotarget; 2018 Oct; 9(80):35123-35140. PubMed ID: 30416684
[TBL] [Abstract][Full Text] [Related]
3. Activation of Protein Tyrosine Phosphatase Receptor Type γ Suppresses Mechanisms of Adhesion and Survival in Chronic Lymphocytic Leukemia Cells.
Montresor A; Toffali L; Fumagalli L; Constantin G; Rigo A; Ferrarini I; Vinante F; Laudanna C
J Immunol; 2021 Jul; 207(2):671-684. PubMed ID: 34162728
[TBL] [Abstract][Full Text] [Related]
4. Comparative analysis of normal versus CLL B-lymphocytes reveals patient-specific variability in signaling mechanisms controlling LFA-1 activation by chemokines.
Montresor A; Bolomini-Vittori M; Simon SI; Rigo A; Vinante F; Laudanna C
Cancer Res; 2009 Dec; 69(24):9281-90. PubMed ID: 19934331
[TBL] [Abstract][Full Text] [Related]
5. JAK tyrosine kinases promote hierarchical activation of Rho and Rap modules of integrin activation.
Montresor A; Bolomini-Vittori M; Toffali L; Rossi B; Constantin G; Laudanna C
J Cell Biol; 2013 Dec; 203(6):1003-19. PubMed ID: 24368807
[TBL] [Abstract][Full Text] [Related]
6. Spleen tyrosine kinase inhibition prevents chemokine- and integrin-mediated stromal protective effects in chronic lymphocytic leukemia.
Buchner M; Baer C; Prinz G; Dierks C; Burger M; Zenz T; Stilgenbauer S; Jumaa H; Veelken H; Zirlik K
Blood; 2010 Jun; 115(22):4497-506. PubMed ID: 20335218
[TBL] [Abstract][Full Text] [Related]
7. ZAP70 expression enhances chemokine-driven chronic lymphocytic leukemia cell migration and arrest by valency regulation of integrins.
Laufer JM; Lyck R; Legler DF
FASEB J; 2018 Sep; 32(9):4824-4835. PubMed ID: 29589978
[TBL] [Abstract][Full Text] [Related]
8. Circulating B-cell chronic lymphocytic leukemia cells display impaired migration to lymph nodes and bone marrow.
Hartmann TN; Grabovsky V; Wang W; Desch P; Rubenzer G; Wollner S; Binsky I; Vallon-Eberhard A; Sapoznikov A; Burger M; Shachar I; Haran M; Honczarenko M; Greil R; Alon R
Cancer Res; 2009 Apr; 69(7):3121-30. PubMed ID: 19293181
[TBL] [Abstract][Full Text] [Related]
9. Elucidating the CXCL12/CXCR4 signaling network in chronic lymphocytic leukemia through phosphoproteomics analysis.
O'Hayre M; Salanga CL; Kipps TJ; Messmer D; Dorrestein PC; Handel TM
PLoS One; 2010 Jul; 5(7):e11716. PubMed ID: 20661426
[TBL] [Abstract][Full Text] [Related]
10. Janus kinases 1 and 2 regulate chemokine-mediated integrin activation and naïve T-cell homing.
Pérez-Rivero G; Cascio G; Soriano SF; Sanz ÁG; de Guinoa JS; Rodríguez-Frade JM; Gomariz RP; Holgado BL; Cabañas C; Carrasco YR; Stein JV; Mellado M
Eur J Immunol; 2013 Jul; 43(7):1745-57. PubMed ID: 23526587
[TBL] [Abstract][Full Text] [Related]
11. Analysis of migratory and prosurvival pathways induced by the homeostatic chemokines CCL19 and CCL21 in B-cell chronic lymphocytic leukemia.
Cuesta-Mateos C; López-Giral S; Alfonso-Pérez M; de Soria VG; Loscertales J; Guasch-Vidal S; Beltrán AE; Zapata JM; Muñoz-Calleja C
Exp Hematol; 2010 Sep; 38(9):756-64, 764.e1-4. PubMed ID: 20488224
[TBL] [Abstract][Full Text] [Related]
12. Rap1 translates chemokine signals to integrin activation, cell polarization, and motility across vascular endothelium under flow.
Shimonaka M; Katagiri K; Nakayama T; Fujita N; Tsuruo T; Yoshie O; Kinashi T
J Cell Biol; 2003 Apr; 161(2):417-27. PubMed ID: 12707305
[TBL] [Abstract][Full Text] [Related]
13. CXCL12 signaling is independent of Jak2 and Jak3.
Moriguchi M; Hissong BD; Gadina M; Yamaoka K; Tiffany HL; Murphy PM; Candotti F; O'Shea JJ
J Biol Chem; 2005 Apr; 280(17):17408-14. PubMed ID: 15611059
[TBL] [Abstract][Full Text] [Related]
14. SOS1, ARHGEF1, and DOCK2 rho-GEFs Mediate JAK-Dependent LFA-1 Activation by Chemokines.
Toffali L; Montresor A; Mirenda M; Scita G; Laudanna C
J Immunol; 2017 Jan; 198(2):708-717. PubMed ID: 27986909
[TBL] [Abstract][Full Text] [Related]
15. CXCL12-induced VLA-4 activation is impaired in trisomy 12 chronic lymphocytic leukemia cells: a role for CCL21.
Ganghammer S; Hutterer E; Hinterseer E; Brachtl G; Asslaber D; Krenn PW; Girbl T; Berghammer P; Geisberger R; Egle A; Zucchetto A; Kruschinski A; Gattei V; Chigaev A; Greil R; Hartmann TN
Oncotarget; 2015 May; 6(14):12048-60. PubMed ID: 25895128
[TBL] [Abstract][Full Text] [Related]
16. Adhesion receptors on peripheral blood leukemic B cells. A comparative study on B cell chronic lymphocytic leukemia and related lymphoma/leukemias.
Csanaky G; Matutes E; Vass JA; Morilla R; Catovsky D
Leukemia; 1997 Mar; 11(3):408-15. PubMed ID: 9067581
[TBL] [Abstract][Full Text] [Related]
17. Small peptide inhibitors of the CXCR4 chemokine receptor (CD184) antagonize the activation, migration, and antiapoptotic responses of CXCL12 in chronic lymphocytic leukemia B cells.
Burger M; Hartmann T; Krome M; Rawluk J; Tamamura H; Fujii N; Kipps TJ; Burger JA
Blood; 2005 Sep; 106(5):1824-30. PubMed ID: 15905192
[TBL] [Abstract][Full Text] [Related]
18. Chemokine unresponsiveness of chronic lymphocytic leukemia cells results from impaired endosomal recycling of Rap1 and is associated with a distinctive type of immunological anergy.
Pye DS; Rubio I; Pusch R; Lin K; Pettitt AR; Till KJ
J Immunol; 2013 Aug; 191(3):1496-504. PubMed ID: 23804711
[TBL] [Abstract][Full Text] [Related]
19. Lymphocyte cytosolic protein 1 is a chronic lymphocytic leukemia membrane-associated antigen critical to niche homing.
Dubovsky JA; Chappell DL; Harrington BK; Agrawal K; Andritsos LA; Flynn JM; Jones JA; Paulaitis ME; Bolon B; Johnson AJ; Byrd JC; Muthusamy N
Blood; 2013 Nov; 122(19):3308-16. PubMed ID: 24009233
[TBL] [Abstract][Full Text] [Related]
20. Dual role of the CXCL12 polymorphism in patients with chronic lymphocytic leukemia.
Butrym A; Gebura K; Iwaszko M; Kuliczkowski K; Bogunia-Kubik K; Mazur G
HLA; 2016 Jun; 87(6):432-8. PubMed ID: 27173875
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]